City Pedia Web Search

Search results

1. Results From The WOW.Com Content Network

2. You might think they’re Bausch & Lomb eye drops. The ... - AOL

   www.aol.com/might-think-bausch-lomb-eye...

   The packaging for Rebright eye drops looks similar to that of Bausch & Lomb’s Lumify eye drops. But, unlike some products in lookalike packaging, this isn’t just a generic knockoff, the FDA says.

3. Brimonidine - Wikipedia

   en.wikipedia.org/wiki/Brimonidine

   Brimonidine is an α 2 agonist medication used to treat open-angle glaucoma, ocular hypertension, and rosacea. [1] [2] In rosacea it improves the redness. [2] It is used as eye drops or applied to the skin. [1] [2] Common side effects when used in the eyes include itchiness, redness, and a dry mouth. [1] Common side effects when used on the ...

4. US FDA warns consumers over copycats of Bausch + Lomb eye drops

   www.aol.com/news/us-fda-warns-consumers-over...

   (Reuters) - The U.S. Food and Drug Administration (FDA) on Wednesday warned consumers not to use unapproved eye drops that closely resemble Bausch + Lomb's Lumify product for redness relief.

5. Over 27 Eye Drops Have Been Recalled: What You Need to Know - AOL

   www.aol.com/eye-drop-recall-know-113000380.html

   In general, eye drops have been recalled over the past year due to either contamination or a lack of sterility. Both are major issues, Aaron Zimmerman, O.D., a clinical professor at The Ohio State ...

6. Bausch & Lomb - Wikipedia

   en.wikipedia.org/wiki/Bausch_&_Lomb

   Bausch & Lomb (since 2010 stylized as Bausch + Lomb [2]) is an American-Canadian eye health products company based in Vaughan, Ontario, Canada. It is one of the world's largest suppliers of contact lenses, [3] lens care products, pharmaceuticals, intraocular lenses, and other eye surgery products. [4] [5] The company was founded in Rochester ...

7. Besifloxacin - Wikipedia

   en.wikipedia.org/wiki/Besifloxacin

   Besifloxacin ( INN / USAN) is a fourth-generation fluoroquinolone antibiotic. The marketed compound is besifloxacin hydrochloride . It was developed by SSP Co. Ltd., Japan, and designated SS734. SSP licensed U.S. and European rights to SS734 for ophthalmic use to InSite Vision Incorporated ( OTC Pink: INSV) in 2000.